ArticleOrthopaedic surgery2026
Preserved Daily Function Despite Significant Muscle Atrophy and Strength Deficits: A Matched-Cohort Study of Iliopsoas Release for Ischiofemoral Impingement.
Article in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThe arthroscopic management of concomitant ischiofemoral impingement (IFI) and femoroacetabular impingement (FAI) frequently necessitates iliopsoas release; however, concerns regarding potential iatrogenic muscle atrophy and strength deficits remain unresolved. Therefore, the purpose of this study was to evaluate the clinical outcomes, volumetric changes, muscle morphology, and objective isokinetic muscle strength in patients undergoing arthroscopic treatment for concomitant IFI and FAI involving iliopsoas release.
methodsThis retrospective matched-cohort study analyzed patients treated between January 2019 and January 2020. It included 15 female patients (IFI + FAI group) who underwent arthroscopic IFI decompression and iliopsoas release, and 15 propensity-matched patients (Isolated FAI group) treated for FAI alone. At a minimum 2-year follow-up, patient-reported outcomes (PROs) were assessed. Muscle morphology was evaluated on MRI using 3D volumetric reconstruction for muscle volume, and the Goutallier classification was used to assess fatty infiltration at three standardized anatomical levels. Functional recovery was objectively measured using isokinetic hip flexor and extensor strength testing at 60°/s and 180°/s, comparing the involved hip to the uninvolved contralateral side. Statistical analyses included paired t-tests, Mann-Whitney U tests, and Wilcoxon signed-rank tests.
resultsBoth groups demonstrated significant improvements in PROs postoperatively (p < 0.001). Volumetric analysis revealed a significant reduction in iliopsoas muscle volume (25.5% decrease) in the IFI + FAI group postoperatively. Despite this volumetric reduction, postoperative MRI demonstrated preservation of muscle quality, as evidenced by low Goutallier grades (Grade < 1) and no significant difference in fatty infiltration compared to the control group (p > 0.05). Functionally, isokinetic testing demonstrated significant deficits in peak flexion torque compared to the healthy contralateral side (p < 0.001). Notably, while outcomes for activities of daily living were satisfactory, a statistically significant difference was observed in the Substantial Clinical Benefit (SCB) achievement rate regarding sports function between the groups.
conclusionIliopsoas release resulted in significant strength deficits, but no significant changes in muscle morphology were observed. However, patient-reported outcomes (PROs) showed improvement, with no significant increase in fatty infiltration, suggesting that functional recovery may occur despite structural deficits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.